Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: A nationwide cohort study

Sang Hoon Lee, Song Yee Kim, Dong Soon Kim, Young Whan Kim, Man Pyo Chung, Soo Taek Uh, Choon Sik Park, Sung Hwan Jeong, Yong Bum Park, Hong Lyeol Lee, Jong Wook Shin, Eun Joo Lee, Jin Hwa Lee, Yangin Jegal, Hyun Kyung Lee, Yong Hyun Kim, Jin Woo Song, Sung Woo Park, Moo Suk Park

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: The clinical course of idiopathic pulmonary fibrosis (IPF) varies widely. Although the GAP model is useful for predicting mortality, survivals have not yet been validated for each GAP score. We aimed to elucidate how prognosis is related to GAP score and GAP stage in IPF patients. Methods: The Korean Interstitial Lung Disease Study Group conducted a national survey to evaluate various characteristics in IPF patients from 2003 to 2007. Patients were diagnosed according to the 2002 criteria of the ATS/ERS. We enrolled 1,685 patients with IPF; 1,262 had undergone DLCO measurement. Patients were stratified based on GAP score (0-7): GAP score Group 0 (n = 26), Group 1 (n = 150), Group 2 (n = 208), Group 3 (n = 376), Group 4 (n = 317), Group 5 (n = 138), Group 6 (n = 39), and Group 7 (n = 8). Results: Higher GAP score and GAP stage were associated with a poorer prognosis (p < 0.001, respectively). Survival time in Group 3 was lower than those in Groups 1 and 2 (p = 0.043 and p = 0.039, respectively), and higher than those in groups 4, 5, and 6 (p = 0.043, p = 0.032, and p = 0.003, respectively). Gender, age, and DLCO (%) differed significantly between Groups 2 and 3. All four variables in the GAP model differed significantly between Groups 3 and 4. Conclusion: The GAP system showed significant predictive ability for mortality in IPF patients. However, prognosis in IPF patients with a GAP score of 3 were significantly different from those in the other stage I groups and stage II groups of Asian patients.

Original languageEnglish
Article number131
JournalRespiratory Research
Volume17
Issue number1
DOIs
Publication statusPublished - 2016 Oct 18

Fingerprint

Idiopathic Pulmonary Fibrosis
Cohort Studies
Survival
Mortality
Interstitial Lung Diseases

Keywords

  • GAP stage
  • Idiopathic pulmonary fibrosis
  • Prognosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Lee, S. H., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., ... Park, M. S. (2016). Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: A nationwide cohort study. Respiratory Research, 17(1), [131]. https://doi.org/10.1186/s12931-016-0454-0

Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score : A nationwide cohort study. / Lee, Sang Hoon; Kim, Song Yee; Kim, Dong Soon; Kim, Young Whan; Chung, Man Pyo; Uh, Soo Taek; Park, Choon Sik; Jeong, Sung Hwan; Park, Yong Bum; Lee, Hong Lyeol; Shin, Jong Wook; Lee, Eun Joo; Lee, Jin Hwa; Jegal, Yangin; Lee, Hyun Kyung; Kim, Yong Hyun; Song, Jin Woo; Park, Sung Woo; Park, Moo Suk.

In: Respiratory Research, Vol. 17, No. 1, 131, 18.10.2016.

Research output: Contribution to journalArticle

Lee, SH, Kim, SY, Kim, DS, Kim, YW, Chung, MP, Uh, ST, Park, CS, Jeong, SH, Park, YB, Lee, HL, Shin, JW, Lee, EJ, Lee, JH, Jegal, Y, Lee, HK, Kim, YH, Song, JW, Park, SW & Park, MS 2016, 'Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: A nationwide cohort study', Respiratory Research, vol. 17, no. 1, 131. https://doi.org/10.1186/s12931-016-0454-0
Lee, Sang Hoon ; Kim, Song Yee ; Kim, Dong Soon ; Kim, Young Whan ; Chung, Man Pyo ; Uh, Soo Taek ; Park, Choon Sik ; Jeong, Sung Hwan ; Park, Yong Bum ; Lee, Hong Lyeol ; Shin, Jong Wook ; Lee, Eun Joo ; Lee, Jin Hwa ; Jegal, Yangin ; Lee, Hyun Kyung ; Kim, Yong Hyun ; Song, Jin Woo ; Park, Sung Woo ; Park, Moo Suk. / Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score : A nationwide cohort study. In: Respiratory Research. 2016 ; Vol. 17, No. 1.
@article{8e2d5c4d987f46829a505d5e0942a015,
title = "Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: A nationwide cohort study",
abstract = "Background: The clinical course of idiopathic pulmonary fibrosis (IPF) varies widely. Although the GAP model is useful for predicting mortality, survivals have not yet been validated for each GAP score. We aimed to elucidate how prognosis is related to GAP score and GAP stage in IPF patients. Methods: The Korean Interstitial Lung Disease Study Group conducted a national survey to evaluate various characteristics in IPF patients from 2003 to 2007. Patients were diagnosed according to the 2002 criteria of the ATS/ERS. We enrolled 1,685 patients with IPF; 1,262 had undergone DLCO measurement. Patients were stratified based on GAP score (0-7): GAP score Group 0 (n = 26), Group 1 (n = 150), Group 2 (n = 208), Group 3 (n = 376), Group 4 (n = 317), Group 5 (n = 138), Group 6 (n = 39), and Group 7 (n = 8). Results: Higher GAP score and GAP stage were associated with a poorer prognosis (p < 0.001, respectively). Survival time in Group 3 was lower than those in Groups 1 and 2 (p = 0.043 and p = 0.039, respectively), and higher than those in groups 4, 5, and 6 (p = 0.043, p = 0.032, and p = 0.003, respectively). Gender, age, and DLCO ({\%}) differed significantly between Groups 2 and 3. All four variables in the GAP model differed significantly between Groups 3 and 4. Conclusion: The GAP system showed significant predictive ability for mortality in IPF patients. However, prognosis in IPF patients with a GAP score of 3 were significantly different from those in the other stage I groups and stage II groups of Asian patients.",
keywords = "GAP stage, Idiopathic pulmonary fibrosis, Prognosis",
author = "Lee, {Sang Hoon} and Kim, {Song Yee} and Kim, {Dong Soon} and Kim, {Young Whan} and Chung, {Man Pyo} and Uh, {Soo Taek} and Park, {Choon Sik} and Jeong, {Sung Hwan} and Park, {Yong Bum} and Lee, {Hong Lyeol} and Shin, {Jong Wook} and Lee, {Eun Joo} and Lee, {Jin Hwa} and Yangin Jegal and Lee, {Hyun Kyung} and Kim, {Yong Hyun} and Song, {Jin Woo} and Park, {Sung Woo} and Park, {Moo Suk}",
year = "2016",
month = "10",
day = "18",
doi = "10.1186/s12931-016-0454-0",
language = "English",
volume = "17",
journal = "Respiratory Research",
issn = "1465-9921",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score

T2 - A nationwide cohort study

AU - Lee, Sang Hoon

AU - Kim, Song Yee

AU - Kim, Dong Soon

AU - Kim, Young Whan

AU - Chung, Man Pyo

AU - Uh, Soo Taek

AU - Park, Choon Sik

AU - Jeong, Sung Hwan

AU - Park, Yong Bum

AU - Lee, Hong Lyeol

AU - Shin, Jong Wook

AU - Lee, Eun Joo

AU - Lee, Jin Hwa

AU - Jegal, Yangin

AU - Lee, Hyun Kyung

AU - Kim, Yong Hyun

AU - Song, Jin Woo

AU - Park, Sung Woo

AU - Park, Moo Suk

PY - 2016/10/18

Y1 - 2016/10/18

N2 - Background: The clinical course of idiopathic pulmonary fibrosis (IPF) varies widely. Although the GAP model is useful for predicting mortality, survivals have not yet been validated for each GAP score. We aimed to elucidate how prognosis is related to GAP score and GAP stage in IPF patients. Methods: The Korean Interstitial Lung Disease Study Group conducted a national survey to evaluate various characteristics in IPF patients from 2003 to 2007. Patients were diagnosed according to the 2002 criteria of the ATS/ERS. We enrolled 1,685 patients with IPF; 1,262 had undergone DLCO measurement. Patients were stratified based on GAP score (0-7): GAP score Group 0 (n = 26), Group 1 (n = 150), Group 2 (n = 208), Group 3 (n = 376), Group 4 (n = 317), Group 5 (n = 138), Group 6 (n = 39), and Group 7 (n = 8). Results: Higher GAP score and GAP stage were associated with a poorer prognosis (p < 0.001, respectively). Survival time in Group 3 was lower than those in Groups 1 and 2 (p = 0.043 and p = 0.039, respectively), and higher than those in groups 4, 5, and 6 (p = 0.043, p = 0.032, and p = 0.003, respectively). Gender, age, and DLCO (%) differed significantly between Groups 2 and 3. All four variables in the GAP model differed significantly between Groups 3 and 4. Conclusion: The GAP system showed significant predictive ability for mortality in IPF patients. However, prognosis in IPF patients with a GAP score of 3 were significantly different from those in the other stage I groups and stage II groups of Asian patients.

AB - Background: The clinical course of idiopathic pulmonary fibrosis (IPF) varies widely. Although the GAP model is useful for predicting mortality, survivals have not yet been validated for each GAP score. We aimed to elucidate how prognosis is related to GAP score and GAP stage in IPF patients. Methods: The Korean Interstitial Lung Disease Study Group conducted a national survey to evaluate various characteristics in IPF patients from 2003 to 2007. Patients were diagnosed according to the 2002 criteria of the ATS/ERS. We enrolled 1,685 patients with IPF; 1,262 had undergone DLCO measurement. Patients were stratified based on GAP score (0-7): GAP score Group 0 (n = 26), Group 1 (n = 150), Group 2 (n = 208), Group 3 (n = 376), Group 4 (n = 317), Group 5 (n = 138), Group 6 (n = 39), and Group 7 (n = 8). Results: Higher GAP score and GAP stage were associated with a poorer prognosis (p < 0.001, respectively). Survival time in Group 3 was lower than those in Groups 1 and 2 (p = 0.043 and p = 0.039, respectively), and higher than those in groups 4, 5, and 6 (p = 0.043, p = 0.032, and p = 0.003, respectively). Gender, age, and DLCO (%) differed significantly between Groups 2 and 3. All four variables in the GAP model differed significantly between Groups 3 and 4. Conclusion: The GAP system showed significant predictive ability for mortality in IPF patients. However, prognosis in IPF patients with a GAP score of 3 were significantly different from those in the other stage I groups and stage II groups of Asian patients.

KW - GAP stage

KW - Idiopathic pulmonary fibrosis

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84992111339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992111339&partnerID=8YFLogxK

U2 - 10.1186/s12931-016-0454-0

DO - 10.1186/s12931-016-0454-0

M3 - Article

C2 - 27756398

AN - SCOPUS:84992111339

VL - 17

JO - Respiratory Research

JF - Respiratory Research

SN - 1465-9921

IS - 1

M1 - 131

ER -